The impact of Cardiovascular Autonomic Neuropathy in diabetes: Is it associated with left ventricular dysfunction?

被引:30
作者
Debono, Miguel
Cachia, Elaine
机构
[1] Luton & Dunstable Hosp NHS Trust, Dept Endocrinol & Diabet, Luton LU4 0DZ, Beds, England
[2] St Lukes Hosp, Dept Med, Guardamangia, Malta
来源
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL | 2007年 / 132卷 / 1-2期
关键词
Cardiovascular Autonomic Neuropathy (CAN); Diabetic Cardiomyopathy (DCM); left ventricular dysfunction; catecholamines; neuropeptidergic system;
D O I
10.1016/j.autneu.2006.11.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cardiovascular Autonomic Neuropathy (CAN) is one of the least understood of all serious complications of diabetes. Besides increasing mortality, CAN may have various clinical sequelae including exercise intolerance, arrhythmias and painless myocardial infarction. But does it also cause left ventricular dysfunction? Patients with diabetes have a greater risk of developing congestive heart failure. Coronary artery disease and hypertension have been notorious in causing left ventricular dysfunction in many of these patients. However, even in their absence, diabetes itself, through several studies, has been proposed to cause the controversial entity, Diabetic Cardiomyopathy (DCM). Various mechanisms have been suggested. CAN through alteration in myocardial blood flow and sympathetic denervation, and through changes in myocardial neurotransmitters, including catecholamines and neurotransmitters of the neuropeptidergic system, has been and is still being studied as one of the main mechanisms to cause left ventricular dysfunction. Earlier detection of CAN and instant initiation of upcoming treatments may be a way to help prevent DCM, and thus improve the morbidity and mortality this causes to patients with diabetes. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 47 条
[1]  
Adams Kirkwood F. Jr., 2001, American Journal of Medicine, V110, p6S
[2]   Regulation of the cardiovascular system by non-adrenergic non-cholinergic nerves [J].
Ahluwalia, A ;
Cellek, S .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1997, 6 (01) :74-79
[3]  
Bielawska AE, 1997, AM J PATHOL, V151, P1257
[4]   Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats [J].
Cellek, S ;
Foxwell, NA ;
Moncada, S .
DIABETES, 2003, 52 (09) :2353-2362
[5]  
Chiao H, 1996, N-S ARCH PHARMACOL, V353, P400
[6]   Autonomic innervation of the human cardiac conduction system: Changes from infancy to senility - An immunohistochemical and histochemical analysis [J].
Chow, LTC ;
Chow, SSM ;
Anderson, RH ;
Gosling, JA .
ANATOMICAL RECORD, 2001, 264 (02) :169-182
[7]   Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the β-adrenergic pathway [J].
Communal, C ;
Singh, K ;
Pimentel, DR ;
Colucci, WS .
CIRCULATION, 1998, 98 (13) :1329-1334
[8]   Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus [J].
Di Carli, M ;
Bianco-Batlles, D ;
Landa, ME ;
Kazmers, A ;
Groehn, H ;
Muzik, O ;
Grunberger, G .
CIRCULATION, 1999, 100 (08) :813-819
[9]   Cardiomyopathy in streptozotocin-induced diabetes involves intra-axonal accumulation of calcitionin gene-related peptide and altered expression of its receptor in rats [J].
Dvoráková, MC ;
Kuncová, J ;
Pfeil, U ;
McGregor, GP ;
Svíglerová, J ;
Slavíková, J ;
Kummer, W .
NEUROSCIENCE, 2005, 134 (01) :51-58
[10]   Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes [J].
Esberg, LB ;
Ren, J .
DIABETOLOGIA, 2003, 46 (10) :1419-1427